Cited by 186Antifungal resistance and susceptibilityFungal Infections and StudiesFungal and yeast genetics research

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity

Open access

D'Haese, Jorien, Theunissen, Koen, Vermeulen, Edith, Schoemans, Hélène, De Vlieger, Greet, Lammertijn, Liesbet, Meersseman, Philippe, Meersseman, Wouter, Lagrou, Katrien, Maertens, Johan·2012·Journal of Clinical Microbiology

DOI 10.1128/jcm.06423-11PMC PMC3318563

Open this paper in CoChat — free account Open PDF

Abstract

Invasive pulmonary aspergillosis (IPA) is frequent and often fatal in immunosuppressed patients. Timely diagnosis of IPA improves survival but is difficult to make. We examined the analytical and clinical validity of galactomannan (GM) testing of bronchoalveolar lavage (BAL) fluid in diagnosing IPA in a mixed population by retrospectively reviewing records of 251 consecutive at-risk patients for whom BAL fluid GM testing was ordered. The performance of the enzyme immunoassay was evaluated by using a range of index cutoffs to define positivity. Three samples were associated with proven IPA, 56 were associated with probable IPA, 63 were associated with possible invasive fungal disease (IFD), and 129 were associated with no IFD. Using a BAL fluid GM index of ≥0.8 (optimal optical density [OD] index cutoff identified by a receiver operating characteristic curve), the sensitivity in diagnosing proven and probable IPA was 86.4%, and the specificity was 90.7%. At this cutoff, positive and negative predictive values were 81% and 93.6%, respectively. However, an OD index value of ≥3.0 corresponded to a 100% specificity, thus ruling the disease in, irrespective of the pretest probability. Conversely, an OD index cutoff of <0.5 corresponded to a high sensitivity, virtually always ruling the disease out. For all values in between, the posttest probability of IPA depends largely on the prevalence of disease in the at-risk population and the likelihood ratio of the OD index value. Detection of GM in BAL fluid samples of patients at risk of IPA has an excellent diagnostic accuracy provided results are interpreted in parallel with clinico-radiological findings and pretest probabilities.

Integrity signals

Registry

Crossref · 10.1128/jcm.06423-11

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Self-citation
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Pulmonary aspergillosis: a clinical review
Kousha, M., Tadi, R., & Soubani, A. O. (2011) · European Respiratory Review · doi:10.1183/09059180.00001011 · Cited by 780
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
Greene, R. E., Schlamm, H. T., Oestmann, J. W., Stark, P., Durand, C. M., Lortholary, O., Wingard, J. R., Herbrecht, R., Ribaud, P., Patterson, T. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/509917 · Cited by 589
Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality
Upton, A., Kirby, K. A., Carpenter, P. A., Boeckh, M., & Marr, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510592 · Cited by 510
Galactomannan in Bronchoalveolar Lavage Fluid
Meersseman, W., Lagrou, K., Maertens, J., Wilmer, A., Hermans, G., Vanderschueren, S., Spriet, I., Verbeken, E., & Van Wijngaerden, E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-606oc · Cited by 496
Laboratory diagnosis of invasive aspergillosis
Hope, W., Walsh, T., & Denning, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70238-3 · Cited by 495
Galactomannan detection for invasive aspergillosis in immunocompromized patients
Leeflang, M., Debets-Ossenkopp, Y. J., Visser, C. E., Scholten, R. J. P. M., Hooft, L., Bijlmer, H. A., Reitsma, J. B., Bossuyt, P. M., & Vandenbroucke‐Grauls, C. M. J. E. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007394 · Cited by 364
AspergillusGalactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid
Musher, B., Fredricks, D. N., Leisenring, W. M., Balajee, S. A., Smith, C. A., & Marr, K. A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5517-5522.2004 · Cited by 283
Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases
Maertens, J. A., Maertens, V., Theunissen, K., Meersseman, W., Meersseman, P., Meers, S., Verbeken, E. K., Verhoef, G. E. G., Eldere, J. V., & Lagrou, K. (2009) · Clinical Infectious Diseases · doi:10.1086/647935 · Cited by 250

Show all 34 references

Sorted by citations

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Donnelly, J. P., Chen, S. C.-J., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1008 · Cited by 2,987
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Molecular and Nonmolecular Diagnostic Methods for Invasive Fungal Infections
Arvanitis, M., Anagnostou, T., Fuchs, B. B., Caliendo, A. M., & Mylonakis, E. E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00091-13 · Cited by 367
Performance of Galactomannan, Beta- d -Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis
Hoenigl, M., Prattes, J., Spiess, B., Wagner, J., Prueller, F., Raggam, R. B., Posch, V., Duettmann, W., Hoenigl, K., Wölfler, A., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00467-14 · Cited by 233
Systematic Review and Meta-Analysis of Detecting Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis
Zou, M., Tang, L., Zhao, S., Zhao, Z., Chen, L., Chen, P., Huang, Z., Li, J., Chen, L., & Fan, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043347 · Cited by 227
Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis
Zhou, W., Li, H., Zhang, Y., Huang, M., He, Q., Li, P., Zhang, F., Shi, Y. P., & Su, X. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00345-17 · Cited by 209
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing
White, P. L., Wingard, J. R., Bretagne, S., Löffler, J., Patterson, T. F., Slavin, M. A., Barnes, R. A., Pappas, P. G., & Donnelly, J. P. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ507 · Cited by 193
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases
Schelenz, S., Barnes, R. A., Barton, R., Cleverley, J., Lucas, S. B., Kibbler, C. C., & Denning, D. W. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70006-x · Cited by 192
The spectrum of pulmonary aspergillosis
Kanj, A., Abdallah, N. H., & Soubani, A. O. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.06.029 · Cited by 172
Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis
Heng, S. C., Morrissey, O., Chen, S. C.-A., Thursky, K., Manser, R. L., Nation, R. L., Kong, D. C.-M., & Slavin, M. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.804033 · Cited by 133
Novel Tests for Diagnosis of Invasive Aspergillosis in Patients with Underlying Respiratory Diseases
Prattes, J., Flick, H., Prüller, F., Koidl, C., Raggam, R. B., Palfner, M., Eigl, S., Buzina, W., Zollner‐Schwetz, I., Thornton, C. R., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1275oc · Cited by 130
Early diagnosis of invasive mould infections and disease
Lamoth, F., & Calandra, T. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx030 · Cited by 126
Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study
Lahmer, T., Kriescher, S., Herner, A., Rothe, K., Spinner, C. D., Schneider, J., Mayer, U., Neuenhahn, M., Hoffmann, D., Geisler, F., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0238825 · Cited by 102
ICU-acquired infections in immunocompromised patients
Kreitmann, L., Helms, J., Martín‐Loeches, I., Salluh, J. I., Poulakou, G., Pène, F., & Nseir, S. (2024) · Intensive Care Medicine · doi:10.1007/s00134-023-07295-2 · Cited by 119
Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study
Boch, T., Spieß, B., Cornely, O. A., Vehreschild, J. J., Rath, P., Steinmann, J., Heinz, W., Hahn, J. R., Krause, S. W., Kiehl, M. G., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.06.021 · Cited by 105
Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia
Boeckh, M., Stevens‐Ayers, T., Travi, G., Huang, M.-L. W., Cheng, G., Xie, H., Leisenring, W. M., Erard, V., Seo, S., Kimball, L. E., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix048 · Cited by 102
Nationwide Surveillance of Azole Resistance in Aspergillus Diseases
Vermeulen, E., Maertens, J. A., Bel, A. D., Nulens, E., Boelens, J., Surmont, I., Mertens, A., Boel, A., & Lagrou, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00233-15 · Cited by 95
Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients
de Heer, K., Gerritsen, M. G., Visser, C. E., & Leeflang, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012399.pub2 · Cited by 89
Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study)
Chakrabarti, A., Kaur, H., Savio, J., Rudramurthy, S. M., Patel, A. K., Shastri, P. S., Pamidimukkala, U., Rajiv Karthik, K., Bhattacharya, S., Kindo, A. J., et al. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.02.005 · Cited by 90
Pneumonia in the neutropenic cancer patient
Evans, S. E., & Ost, D. E. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000156 · Cited by 84
Performance of the Bronchoalveolar Lavage FluidAspergillusGalactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study
Jenks, J. D., Prattes, J., Frank, J., Spieß, B., Mehta, S. R., Boch, T., Buchheidt, D., & Hoenigl, M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1281 · Cited by 78
Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients
Ergün, M., Brüggemann, R. J. M., Alanio, A., Dellière, S., van Arkel, A., Bentvelsen, R. G., Rijpstra, T., der Brugge, S. V. D. S.-V., Lagrou, K., Janssen, N. A. F., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01229-21 · Cited by 78
Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
Lamoth, F. (2016) · Journal of Fungi · doi:10.3390/jof2030022 · Cited by 76
Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study
Harrison, N., Mitterbauer, M., Tobudic, S., Kalhs, P., Rabitsch, W., Greinix, H., Burgmann, H., Willinger, B., Presterl, E., & Forstner, C. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1329-6 · Cited by 73
Biosensors and Diagnostics for Fungal Detection
Hussain, K. K., Malavia, D., Johnson, E. M., Littlechild, J. A., Winlove, C. P., Vollmer, F., & Gow, N. A. R. (2020) · Journal of Fungi · doi:10.3390/jof6040349 · Cited by 75
New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies
Patterson, T. F., & Donnelly, J. P. (2019) · Journal of Fungi · doi:10.3390/jof5010009 · Cited by 72
Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
Heldt, S., & Hoenigl, M. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0275-8 · Cited by 69
Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis in Solid Organ Transplant Patients
Willinger, B., Lackner, M., Lass‐Flörl, C., Prattes, J., Posch, V., Selitsch, B., Eschertzhuber, S., Hönigl, K., Koidl, C., Sereinigg, M., et al. (2014) · Transplantation · doi:10.1097/tp.0000000000000153 · Cited by 63
Pulmonary Aspergillosis in Patients with Suspected Ventilator-Associated Pneumonia in UK ICUs
Loughlin, L., Hellyer, T. P., White, P. L., McAuley, D. F., Morris, A. C., Posso, R. B., Richardson, M. D., Denning, D. W., Simpson, A. J., & McMullan, R. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0355oc · Cited by 66
Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies
Heng, S. C., Chen, S. C. ‐., Morrissey, C. O., Thursky, K., Manser, R. L., de Silva, H. D., Halliday, C. L., Seymour, J. F., Nation, R. L., Kong, D. C. M., et al. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.03.020 · Cited by 61
Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients
Fortün, J., Martín‐Dávila, P., de la Pedrosa, E. G. G., Silva, J. T., García‐Rodríguez, J., Benito, D., Rullo, E. V., Castaño, F., Fernández‐Ruiz, M., Lázaro, F., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.02.019 · Cited by 62
Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients
Gonçalves, S. M., Lagrou, K., Rodrigues, C. S., Campos, C. F., Bernal‐Martínez, L., Rodrigues, F. J. S., Silvestre, R., Alcázar‐Fuoli, L., Maertens, J. A., Cunha, C., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02362 · Cited by 60
Multi-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19
Pasero, D., Cossu, A. P., & Terragni, P. (2021) · Microorganisms · doi:10.3390/microorganisms9081773 · Cited by 60
Diagnostic Bronchoscopy in Solid-Organ and Hematopoietic Stem Cell Transplantation
Harris, B., Lowy, F. D., Stover, D. E., & Arcasoy, S. M. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201212-114fr · Cited by 53
American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients
Dadwal, S., Hohl, T. M., Fisher, C. E., Boeckh, M., Papanicolaou, G., Carpenter, P. A., Fisher, B. T., Slavin, M. A., & Kontoyiannis, D. P. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2020.10.003 · Cited by 51
Diagnosing invasive pulmonary aspergillosis in ICU patients: putting the puzzle together
Blot, S. I., Rello, J., & Koulenti, D. (2019) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000637 · Cited by 53
Blood Aspergillus PCR: The Good, the Bad, and the Ugly
Egger, M., Jenks, J. D., Hoenigl, M., & Prattes, J. (2020) · Journal of Fungi · doi:10.3390/jof6010018 · Cited by 53
Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases
Zhao, Y., Stensvold, C. R., Perlin, D. S., & Arendrup, M. C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt071 · Cited by 48
The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients
Ambasta, A., Carson, J. A., & Church, D. L. (2015) · Medical Mycology · doi:10.1093/mmy/myv026 · Cited by 45
The Serum Opsonin L-ficolin Is Detected in Lungs of Human Transplant Recipients Following Fungal Infections and Modulates Inflammation and Killing ofAspergillus fumigatus
Bidula, S. M., Sexton, D. W., Abdolrasouli, A., Shah, A., Reed, A. K., Armstrong-James, D. P. H., & Schelenz, S. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv027 · Cited by 44
Nonmolecular Methods for the Diagnosis of Respiratory Fungal Infections
Lamoth, F., & Alexander, B. D. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.02.006 · Cited by 44
Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India
Rawat, A. K., Vignesh, P., Sharma, A. K., Shandilya, J. K., Sharma, M., Suri, D., Gupta, A., Gautam, V., Ray, P., Rudramurthy, S. M., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0382-x · Cited by 44
H‐ficolin binds A spergillus fumigatus leading to activation of the lectin complement pathway and modulation of lung epithelial immune responses
Bidula, S. M., Sexton, D. W., Yates, M. P., Abdolrasouli, A., Shah, A., Wallis, R., Reed, A. K., Armstrong-James, D. P. H., & Schelenz, S. (2015) · Immunology · doi:10.1111/imm.12501 · Cited by 45
Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy
Hoenigl, M., Seeber, K., Koidl, C., Buzina, W., Wölfler, A., Duettmann, W., Wagner, J., Strenger, V., & Krause, R. (2013) · Mycoses · doi:10.1111/myc.12060 · Cited by 42
Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices
Gaffney, S. M., Kelly, D., Rameli, P. M., Kelleher, E. M., & Martín‐Loeches, I. (2023) · Apmis · doi:10.1111/apm.13316 · Cited by 46
Non-cultural methods for the diagnosis of invasive fungal disease
Mikulska, M., Furfaro, E., & Viscoli, C. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.979788 · Cited by 40
Frequency, diagnosis and management of fungal respiratory infections
Hayes, G., & Denning, D. W. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835f1ad1 · Cited by 39
Invasive Fungal Infections
Schuetz, A. N. (2013) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2013.03.009 · Cited by 39
Diagnostic Value of Microbial Cell-free DNA Sequencing for Suspected Invasive Fungal Infections: A Retrospective Multicenter Cohort Study
Huygens, S., Schauwvlieghe, A. F. A. D., Wlazlo, N., Moors, I., Boelens, J., Reynders, M., Chong, G. M., Klaassen, C. H. W., & Rijnders, B. J. A. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae252 · Cited by 37
Invasive Aspergillosis in the Intensive Care Unit
Townsend, L., & Martín‐Loeches, I. (2022) · Diagnostics · doi:10.3390/diagnostics12112712 · Cited by 42
The performance of galactomannan in combination with 1,3-β-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: Evidences from 13 studies
Zhang, L., Guo, Z., Xie, S., Zhou, J., Chen, G., Feng, J., & Huang, Y. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.08.005 · Cited by 36
Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation
Young, A., Juárez, M. M. L., & Evans, S. E. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.009 · Cited by 36
Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis
Armaki, M. T., Hedayati, M. T., Moqarabzadeh, V., Ansari, S., Omran, S. M., Zarrinfar, H., Saber, S., Verweij, P. E., Denning, D. W., & Seyedmousavi, S. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000512 · Cited by 36
The Performance of Real-Time PCR, Galactomannan, and Fungal Culture in the Diagnosis of Invasive Aspergillosis in Ventilated Patients with Chronic Obstructive Pulmonary Disease (COPD)
Aquino, V. R., Nagel, F., Andreolla, H. F., de-Paris, F., Xavier, M. O., Goldani, L. Z., Denning, D. W., & Pasqualotto, A. C. (2012) · Mycopathologia · doi:10.1007/s11046-012-9531-1 · Cited by 35
COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study
Hurt, W., Youngs, J., Ball, J., Edgeworth, J., Hopkins, P. A., Jenkins, D. R., Leaver, S. K., Mazzella, A., Molloy, S. F., Schelenz, S., et al. (2023) · Thorax · doi:10.1136/thorax-2023-220002 · Cited by 34
Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment
Heylen, J., Vanbiervliet, Y., Maertens, J. A., Rijnders, B. J. A., & Wauters, J. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1777769 · Cited by 35
False positive bronchoalveolar lavage galactomannan: Effect of host and cut‐off value
Farmakiotis, D., Le, A., Weiss, Z., Ismail, N., Kubiak, D. W., & Koo, S. (2018) · Mycoses · doi:10.1111/myc.12867 · Cited by 31
Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study
Giacobbe, D. R., Prattes, J., Wauters, J., Dettori, S., Signori, A., Salmanton‐García, J., Maertens, J. A., Bourgeois, M., Reynders, M., Rutsaert, L., et al. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.02298-21 · Cited by 30
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests.
Orsi, C. F., Bettua, C., Pini, P., Venturelli, C., Regina, A. L., Morace, G., Luppi, M., Forghieri, F., Bigliardi, S., Luppi, F., et al. (2015) · PubMed · Cited by 30
The current management landscape: aspergillosis: Table 1.
Maertens, J. A., Blennow, O., Duarte, R. F., & Muñoz, P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw393 · Cited by 29
Invasive aspergillosis in liver transplant recipients
Melenotte, C., Aimanianda, V., Slavin, M. A., Aguado, J. M., Armstrong-James, D. P. H., Chen, Y., Husain, S., van Delden, C., Saliba, F., Lefort, A., et al. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14049 · Cited by 33
Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients
Aigner, M., Wanner, M., Kreidl, P., Lass‐Flörl, C., & Lackner, M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00138-19 · Cited by 28
Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid
Egger, M., Penziner, S., Dichtl, K., Gornicec, M., Kriegl, L., Krause, R., Khong, E., Mehta, S. R., Vargas, M. V., Gianella, S., et al. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.00215-22 · Cited by 27
Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease
Buil, J. B., Huygens, S., Dunbar, A., Schauwvlieghe, A. F. A. D., Reynders, M., Langerak, D., van Dijk, K., Bruns, A. H. W., Haas, P., Postma, D. F., et al. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.00044-23 · Cited by 27
Current Challenges in the Microbiological Diagnosis of Invasive Aspergillosis
Guinea, J., & Bouza, E. (2014) · Mycopathologia · doi:10.1007/s11046-014-9763-3 · Cited by 29
Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples
Danylo, A., Courtemanche, C., Pelletier, R., & Boudreault, A. A. (2014) · Medical Mycology · doi:10.1093/mmy/myu025 · Cited by 26
Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis
Boch, T., Buchheidt, D., Spieß, B., Miethke, T., Hofmann, W., & Reinwald, M. (2015) · Mycoses · doi:10.1111/myc.12434 · Cited by 26
Diagnostics and Susceptibility Testing in Aspergillus
Bernal-Martínez, L., Alastruey-Izquierdo, A., & Cuenca-Estrella, M. (2016) · Future Microbiology · doi:10.2217/fmb.15.140 · Cited by 25
Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients - A retrospective cohort study
Kuo, C., Wang, S., Tsai, H., Su, P., Cia, C.-T., Lai, C., Chen, C.-W., Shieh, C.-C. K., & Lin, S. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.03.005 · Cited by 24
Biomarkers for Invasive Aspergillosis: The Challenges Continue
Johnson, G. L., Ferrini, A., Dolan, S. K., Nolan, T., Agrawal, S. G., Doyle, S., & Bustin, S. A. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.13.129 · Cited by 24
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID ‐19‐associated pulmonary aspergillosis
Ghazanfari, M., Charati, J. Y., Davoodi, L., Arastehfar, A. A., Moazeni, M., Abastabar, M., Haghani, I., Mayahi, S., Hoenigl, M., Pan, W., et al. (2022) · Mycoses · doi:10.1111/myc.13518 · Cited by 23
Current and Future Pathways in Aspergillus Diagnosis
Dobiáš, R., Stevens, D. A., & Havlı́ček, V. (2023) · Antibiotics · doi:10.3390/antibiotics12020385 · Cited by 22
Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
Russo, A., Giuliano, S., Vena, A., Lucidi, C., Falcone, M., Raponi, G., Merli, M., & Venditti, M. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.05.015 · Cited by 22
Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients
Ao, Z., Xu, H., Li, M., Liu, H., Deng, M., & Liu, Y. (2023) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2022-001358 · Cited by 21
Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
Zhuang, Q., Ma, H., Zhang, Y., Chen, L., Wang, L., Zheng, L., Deng, Z., & Chen, Z. (2017) · Canadian Respiratory Journal · doi:10.1155/2017/3685261 · Cited by 20
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update
Schelenz, S., Abdolrasouli, A., Armstrong-James, D. P. H., Ashbee, H. R., Barton, R., Bicanic, T. A., Borman, A., Brown, L., Eades, C., Ferreras-Antolin, L., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00550-x · Cited by 23
Diagnostic value of bronchoalveolar lavage fluid galactomannan assay for invasive pulmonary aspergillosis in adults: A meta‐analysis
Li, C., Sun, L., Liu, Y., Zhou, H., Chen, J., She, M., & Wang, Y. (2022) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13792 · Cited by 19
Pediatric Invasive Aspergillosis
Wattier, R. L., & Ramírez-Àvila, L. (2016) · Journal of Fungi · doi:10.3390/jof2020019 · Cited by 19
Evaluation of the new Asp ID polymerase chain reaction assay for detection of Aspergillus species: A pilot study
Prattes, J., Hoenigl, M., Zinke, S. E. ‐., Heldt, S., Eigl, S., Johnson, G. L., Bustin, S. A., Stelzl, E., & Kessler, H. H. (2018) · Mycoses · doi:10.1111/myc.12757 · Cited by 16
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
Dib, R. W., Hachem, R. Y., Chaftari, A., Ghaly, F., Jiang, Y., & RAAD, I. I. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3584-9 · Cited by 16
Bronchoalveolar lavage fluid and serum 1,3-β-d-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance
Weinbergerová, B., Kabut, T., Kocmanová, I., Lengerová, M., Pospı́šil, Z., Král, Z., & Mayer, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-75132-3 · Cited by 16
Rational approach to pulmonary infiltrates in leukemia and transplantation
Kontoyiannis, D. P. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.10.012 · Cited by 16
Pathology of Pulmonary Infection
Kradin, R. L., & Mark, E. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44585-6.00008-4 · Cited by 16
Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis
Khodavaysi, S., Hedayati, M. T., Alialy, M., Habibi, M. R., & Badali, H. (2015) · Current Medical Mycology · doi:10.18869/acadpub.cmm.1.1.12 · Cited by 15
Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls
White, P. L. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000791 · Cited by 14
Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
Clancy, C. J., & Nguyen, M. H. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac081 · Cited by 14
Infections in Leukemia
Chandran, R., Hakki, M., & Spurgeo, S. (2012) · InTech eBooks · doi:10.5772/50193 · Cited by 15
Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
Cao, X., Li, Y.-P., Xie, L., Zhang, H.-L., Qin, Y.-S., & Guo, X. (2020) · BioMed Research International · doi:10.1155/2020/5434589 · Cited by 13
Invasive pulmonary aspergillosis among patients with severe community-acquired pneumonia and influenza in ICUs: a retrospective cohort study
Lee, W., Chang, C., Ho, M.-C., Lin, C., Leu, S., Lin, C., Fang, Y., Huang, S., Lin, Y., Chuang, M., et al. (2024) · Pneumonia · doi:10.1186/s41479-024-00129-9 · Cited by 14
Directed therapy for fungal infections: focus on aspergillosis
Barnes, R. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt227 · Cited by 12
Evaluation of a quantitative serum Aspergillus fumigatus‐specific IgM assay for diagnosis of chronic pulmonary aspergillosis
Yao, Y., Zhou, H., Shen, Y., Yang, Q., Ye, J., Fu, Y., Lu, G., Lou, H., Yu, Y., & Zhou, J. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12957 · Cited by 12
Diagnostic Approach to Pneumonia in Immunocompromised Hosts
Ullah, N., Fusco, L., Ametrano, L., Bartalucci, C., Giacobbe, D. R., Vena, A., Mikulska, M., & Bassetti, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020389 · Cited by 11
Nucleic acid amplification methodologies for the detection of pulmonary mold infections
McCarthy, M. W., Petraitienė, R., & Walsh, T. J. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1293528 · Cited by 11
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE.
Cefalo, M., Puxeddu, E., Sarmati, L., Paterno, G., Fontana, C., Nassa, D., Pane, G., Bellis, E. D., Palmieri, R., Buzzatti, E., et al. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2019.065 · Cited by 11
New serological markers in medical mycology: (1,3)-(-D-glucan and Aspergillus galactomannan
Ostrosky‐Zeichner, L., Vitale, R. G., & Nucci, M. (2012) · Infectio · doi:10.1016/s0123-9392(12)70028-0 · Cited by 11
Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis
Friedman, D. Z. P., Theel, E. S., Walker, R. C., Vikram, H. R., Razonable, R. R., & Vergidis, P. I. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae114 · Cited by 10
COVID-19-Associated Pulmonary Aspergillosis in Patients with Acute Leukemia: A Single-Center Study
Rajic, J., Gmizić, I., Gunjak, T., Milošević, V., Pantić, N., Sabljić, N., Mitrović, M., Djurić-Stefanović, A., Lazić, L., Jovanović, S., et al. (2021) · Journal of Fungi · doi:10.3390/jof7110890 · Cited by 10
Current Analytical Methods and Challenges for the Clinical Diagnosis of Invasive Pulmonary Aspergillosis Infection
Schwarz, M. C. R., Moskaluk, A. E., Daniels, J. B., VandeWoude, S., & Reynolds, M. M. (2024) · Journal of Fungi · doi:10.3390/jof10120829 · Cited by 10

Authors: D'Haese, J., Theunissen, K., Vermeulen, E., Schoemans, H., De Vlieger, G., Lammertijn, L., Meersseman, P., Meersseman, W., Lagrou, K., & Maertens, J.
Affiliations: Universitair Ziekenhuis Leuven (BE)
Department of Hematology, Acute Leukemia and Stem Cell Transplantation Unit, Medical Intensive Care Unit, Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Catholic University of Leuven, Leuven, Belgium
Department of General Internal Medicine, Medical Intensive Care Unit, Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Catholic University of Leuven, Leuven, Belgium
ORCID: Vermeulen, Edith
Meersseman, Philippe
Meersseman, Wouter
Lagrou, Katrien
Maertens, Johan
Venue: Journal of Clinical Microbiology
Publisher: American Society for Microbiology
Published: 2012-04
Volume: 50
Issue: 4
Pages: 1258-1263
ISSN: 0095-1137 (ISSN-L)
1098-660X
DOI: 10.1128/jcm.06423-11
PMC: PMC3318563
OpenAlex: W2069266003
Cited by: 186
References: 34
Citations by year: 2026: 4 · 2025: 11 · 2024: 11 · 2023: 20 · 2022: 12 · 2021: 12 · 2020: 14 · 2019: 15 · 2018: 11 · 2017: 20 · 2016: 10 · 2015: 15 · 2014: 16 · 2013: 10 · 2012: 5
FWCI: 10.16
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Clinical Microbiology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords: invasive pulmonary aspergillosis, galactomannan, bronchoalveolar lavage fluid, enzyme immunoassay, diagnostic accuracy, sensitivity and specificity, predictive value, likelihood ratios, pretest probability, invasive fungal infections, immunocompromised patients
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Bronchoalveolar Lavage Fluid, Female, Galactose, Humans, Male, Mannans, Middle Aged, Retrospective Studies, ROC Curve, Immunocompromised Host, Invasive Pulmonary Aspergillosis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks